Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

NASDAQ:CBAT - Nasdaq - US14986C1027 - Common Stock - Currency: USD

1.07  -0.01 (-0.93%)

After market: 1.06 -0.01 (-0.93%)

Fundamental Rating

4

CBAT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 94 industry peers in the Electrical Equipment industry. While CBAT is still in line with the averages on profitability rating, there are concerns on its financial health. CBAT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
In the past year CBAT had a positive cash flow from operations.
In multiple years CBAT reported negative net income over the last 5 years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of CBAT (0.12%) is better than 68.09% of its industry peers.
Looking at the Return On Equity, with a value of 0.31%, CBAT is in the better half of the industry, outperforming 68.09% of the companies in the same industry.
CBAT has a better Return On Invested Capital (0.86%) than 63.83% of its industry peers.
Industry RankSector Rank
ROA 0.12%
ROE 0.31%
ROIC 0.86%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CBAT's Profit Margin of 0.25% is fine compared to the rest of the industry. CBAT outperforms 68.09% of its industry peers.
CBAT's Profit Margin has declined in the last couple of years.
CBAT's Operating Margin of 1.09% is fine compared to the rest of the industry. CBAT outperforms 63.83% of its industry peers.
CBAT has a Gross Margin of 21.68%. This is comparable to the rest of the industry: CBAT outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of CBAT has grown nicely.
Industry RankSector Rank
OM 1.09%
PM (TTM) 0.25%
GM 21.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CBAT remains at a similar level compared to 1 year ago.
CBAT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CBAT has been reduced compared to a year ago.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CBAT has an Altman-Z score of 0.14. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
CBAT's Altman-Z score of 0.14 is in line compared to the rest of the industry. CBAT outperforms 46.81% of its industry peers.
The Debt to FCF ratio of CBAT is 51.08, which is on the high side as it means it would take CBAT, 51.08 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 51.08, CBAT is doing good in the industry, outperforming 63.83% of the companies in the same industry.
CBAT has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
CBAT's Debt to Equity ratio of 0.28 is in line compared to the rest of the industry. CBAT outperforms 56.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 51.08
Altman-Z 0.14
ROIC/WACC0.14
WACC6%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.82 indicates that CBAT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, CBAT is doing worse than 81.91% of the companies in the same industry.
CBAT has a Quick Ratio of 0.82. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.64, CBAT is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.64
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -100.00% in the last year.
CBAT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -42.83% yearly.
CBAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.85%.
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.
EPS 1Y (TTM)-100%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-118.18%
Revenue 1Y (TTM)-30.85%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-40.6%

3.2 Future

The Earnings Per Share is expected to decrease by -20.77% on average over the next years. This is quite bad
CBAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.08% yearly.
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y23.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.1 -0.1

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 13.11 indicates a correct valuation of CBAT.
Based on the Price/Forward Earnings ratio, CBAT is valued cheaply inside the industry as 88.30% of the companies are valued more expensively.
CBAT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE N/A
Fwd PE 13.11
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CBAT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CBAT is cheaper than 95.74% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CBAT is valued a bit cheaper than the industry average as 63.83% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 145.57
EV/EBITDA 7.82
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

CBAT's earnings are expected to decrease with -20.77% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (7/11/2025, 8:00:02 PM)

After market: 1.06 -0.01 (-0.93%)

1.07

-0.01 (-0.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners2.08%
Inst Owner Change0%
Ins Owners25.43%
Ins Owner Change0%
Market Cap96.24M
Analysts0
Price Target1.53 (42.99%)
Short Float %1.47%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-42.35%
Min Revenue beat(2)-50.36%
Max Revenue beat(2)-34.33%
Revenue beat(4)0
Avg Revenue beat(4)-33.59%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)-24.56%
Revenue beat(8)1
Avg Revenue beat(8)-19.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-400%
EPS NY rev (3m)-209.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.11
P/S 0.63
P/FCF 145.57
P/OCF 4.25
P/B 0.8
P/tB 0.8
EV/EBITDA 7.82
EPS(TTM)0
EYN/A
EPS(NY)0.08
Fwd EY7.63%
FCF(TTM)0.01
FCFY0.69%
OCF(TTM)0.25
OCFY23.52%
SpS1.7
BVpS1.34
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.12%
ROE 0.31%
ROCE 1.22%
ROIC 0.86%
ROICexc 0.91%
ROICexgc 0.92%
OM 1.09%
PM (TTM) 0.25%
GM 21.68%
FCFM 0.43%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 51.08
Debt/EBITDA 3.07
Cap/Depr 234.88%
Cap/Sales 14.39%
Interest Coverage 3.34
Cash Conversion 205.51%
Profit Quality 176.53%
Current Ratio 0.82
Quick Ratio 0.64
Altman-Z 0.14
F-Score3
WACC6%
ROIC/WACC0.14
Cap/Depr(3y)228.34%
Cap/Depr(5y)286.62%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-118.18%
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.85%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-40.6%
Revenue Next Year10.75%
Revenue Next 2Y23.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-90.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.61%
OCF growth 3YN/A
OCF growth 5YN/A